H. Nehoff

发表

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

K. Greish, H. Nehoff, N. Parayath, 2014, International journal of nanomedicine.

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

K. Greish, H. Nehoff, S. Taurin, 2016, International journal of nanomedicine.

In Vivo Evaluation of Acute and Chronic Nanotoxicity

K. Greish, H. Nehoff, N. Parayath, 2014 .

The Influence of Drug Loading on Caveolin-1 Mediated Intracellular Internalization of Doxorubicin Nanomicelles in vitro

K. Greish, H. Nehoff, N. Parayath, 2014 .

Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor

K. Greish, H. Nehoff, S. Taurin, 2019, Journal of drug targeting.

Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model

K. Greish, H. Nehoff, N. Parayath, 2016, International journal of nanomedicine.

Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells

K. Greish, H. Nehoff, N. Parayath, 2015, International journal of nanomedicine.

ALK and IGF-1R as independent targets in crizotinib resistant lung cancer

H. Nehoff, M. Nimick, J. Ashton, 2017, Scientific Reports.

A Novel Role for Raloxifene Nanomicelles in Management of Castrate Resistant Prostate Cancer

Khaled Greish, K. Greish, H. Nehoff, 2014, BioMed research international.

A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme

K. Greish, H. Nehoff, N. Parayath, 2015, Oncotarget.

Tumor Vasculature, EPR Effect, and Anticancer Nanomedicine: Connecting the Dots

K. Greish, H. Nehoff, S. Taurin, 2013 .

Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?

K. Greish, H. Nehoff, S. Taurin, 2012, Journal of controlled release : official journal of the Controlled Release Society.

The use of combination tyrosine kinase inhibitors for the treatment of glioblastoma multiforme

H. Nehoff, 2016 .

Falcine meningioma masquerading as biliary colic – Case report and literature review

H. Nehoff, S. Dimou, S. Jackson, 2021, Journal of Clinical Neuroscience.

Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer

K. Greish, H. Nehoff, S. Taurin, 2013, Journal of drug targeting.

Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme

K. Greish, H. Nehoff, N. Parayath, 2017, Journal of drug targeting.

Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale

A. Gray, P. Glue, H. Nehoff, 2020, Journal of psychopharmacology.

Toxicological Assessment of Nanomedicine

K. Greish, H. Nehoff, S. Taurin, 2013 .

ALK and IGF-1R as independent targets in crizotinib resistant lung cancer

H. Nehoff, M. Nimick, J. Ashton, 2017, Scientific Reports.

Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model

K. Greish, H. Nehoff, P. Brownjohn, 2015, Journal of drug targeting.

Yersinia enterocolitica associated myopericarditis: case report and review of the literature.

H. Nehoff, I. Crozier, H. Isenman, 2022, The New Zealand medical journal.